IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — ATR

September 10, 2026View Source ↗

AptarGroup, Inc. announced that Aditya J. Gandhi resigned as Vice President and Chief Accounting Officer effective September 11, 2026, to pursue opportunities outside the Chicago area. The resignation was not due to disagreements regarding operations or policies. Daniel Ackerman has been appointed Senior Vice President and Interim Chief Accounting Officer effective the same date. Mr. Ackerman previously served as Chief Accounting Officer from August 2024 until June 2026 and currently serves as Senior Vice President, Finance for Aptar Pharma. He rejoins the role reporting to Executive Vice President and Chief Financial Officer Vanessa Kanu while a permanent successor is identified. The company operates in the packaging solutions industry.

September 1, 2026View Source ↗

AptarGroup, Inc. announced that its Board of Directors increased in size from ten to eleven members and appointed Gael Touya as a director, effective September 1, 2026. Mr. Touya will serve until the 2028 annual meeting and is not expected to join any board committees. This appointment coincides with his transition to President and Chief Executive Officer, succeeding Stephan B. Tanda, who retired on the same date. The filing confirms no special arrangements or family relationships exist between Mr. Touya and other executives. AptarGroup, Inc. operates in the packaging industry, designing and manufacturing components for pharmaceuticals, consumer health, food, and home care products.

July 30, 2026View Source ↗

AptarGroup, Inc. reported second quarter 2026 results with reported sales increasing 6% to $1.03 billion and core sales rising 1%. Reported net income was $88 million, or $1.36 per diluted share, compared to $1.67 in the prior year period. Adjusted earnings per share were $1.42. The company announced a quarterly cash dividend of $0.48 per share with a record date of July 30, 2026, and payment on August 20, 2026. CEO Stephan B. Tanda is concluding his tenure, handing over to Gael Touya on September 1, 2026. AptarGroup operates in the drug delivery, dosing, protection technologies, and consumer product dispensing industry.